Wellbutrin Plaintiffs Step Up Fight For Docs' Release

Law360, New York (August 11, 2009, 5:15 PM EDT) -- The direct purchaser plaintiffs in an antitrust class action alleging that Biovail Corp. and GlaxoSmithKline PLC conspired to stifle the market for a generic version of antidepressant Wellbutrin XL have charged ahead with their battle to have a set of documents related to several underlying patent cases released for discovery.

The group filed a memorandum of law Monday in the U.S. District Court for the Eastern District of Pennsylvania in support of an earlier motion to compel discovery, asking the court to strike down Biovail and...
To view the full article, register now.